Training the Experts to Find New Treatments

Press Release (ePRNews.com) - San Diego, CA - Nov 11, 2016 - Speid & Associates announces that  Drug Development Boot CampTM  will take place at The Harvard Club, 374 Commonwealth Avenue, Boston, on November 16-17, 2016.

Dr. Lorna Speid is an expert in regulatory affairs and drug development of new medicines. She is the Founder and Co-chair of the Drug Development Boot CampTM ​. She said:

“This is our seventh year in providing intensive training in drug development. With the advance in genomics and medical sciences, drug developers must hone their skills to more effectively take advantage of what is now available to them. Using accelerated learning approaches, the Drug Development Boot CampTM seeks to challenge experienced researchers and drug developers to more effectively make an impact for patients.”

Dr. Lorna Speid, Founder and Co-chair of the Drug Development Boot CampTM

“This is our seventh year in providing intensive training in drug development. With the advance in genomics and medical sciences, drug developers must hone their skills to more effectively take advantage of what is now available to them. Using accelerated learning approaches, the Drug Development Boot CampTM seeks to challenge experienced researchers and drug developers to more effectively make an impact for patients.”

For more information about the Boot Camp, visit www.drugstomarket.com/harvarddrugbootcamp/

Applications for places are still being accepted.  Dr. Speid can be contacted at lspeid@sndtm.com or Tel: 858 793 1295. Pharma companies and service companies that wish to exhibit or sponsor the Boot Camp can contact Dr. Speid at the same contact number and email address.

About Speid & Associates, Inc.

Speid & Associates, Inc. provides global and strategic regulatory affairs support for the development of new chemical and biological entities.

Media Contact:

Lorna Speid, PhD
(858) 793-1295 | lspeid@sndtm.com

Source : Speid & Associates, Inc.

You may also like this  

DISCLAIMER : If you have any concerns regarding this press release, please contact the Author / Media Contact / Business of this press release. ePRNews is not resposible for the accuracy of the news posted and do not endorse, support any product/services/business mentioned and hereby disclaims any content contained in this press release.

Login

Or using ePRNews Account

Don't have an account ? Sign Up

Register New Account

Or form here

Already have an account ? Login

Reset Password

Already have an account ? Login